Načítá se...
Chronic Subcutaneous BNP Therapy in Asymptomatic Systolic Heart Failure
AIM: We have previously reported that asymptomatic systolic heart failure (HF) is characterized by an impaired renal response to volume expansion due to lack of activation of urinary cGMP which is corrected by subcutaneous B-type natriuretic peptide (BNP). In the current study we sought to define th...
Uloženo v:
| Vydáno v: | Eur J Heart Fail |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4874857/ https://ncbi.nlm.nih.gov/pubmed/26806605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.468 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|